Denali Therapeutics Inc. (DNLI)

Denali Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	174.96	127.11	218.04	293.48	507.14
Short-Term Investments	657.37	907.41	1,118	571.93	962.55
Cash & Short-Term Investments	832.33	1,035	1,336	865.41	1,470
Cash Growth	-19.54%	-22.58%	54.40%	-41.12%	253.84%
Accounts Receivable	2.17	3.42	9.28	-	-
Other Receivables	-	-	-	1.23	5.67
Receivables	2.17	3.42	9.28	1.23	5.67
Prepaid Expenses	29.93	26.21	26.82	30.6	20.28
Total Current Assets	864.44	1,064	1,372	897.23	1,496
Property, Plant & Equipment	125.63	71.64	74.52	69.61	73.46
Long-Term Investments	374.37	-	-	425.45	32.7
Other Long-Term Assets	9.74	18.14	13.4	11.87	2.46
Total Assets	1,374	1,154	1,460	1,404	1,604
Accounts Payable	11.14	9.48	2.79	4.78	1.07
Accrued Expenses	64.91	61.24	59.37	47.71	42.46
Current Portion of Leases	12.03	7.26	7.32	5.45	4.69
Current Unearned Revenue	-	-	290.05	320.3	23.48
Other Current Liabilities	14.13	-	4.39	-	-
Total Current Liabilities	102.21	77.98	363.92	378.25	71.7
Long-Term Leases	42.29	44.98	53.03	58.55	64.18
Long-Term Unearned Revenue	-	-	0.48	4.69	317.17
Other Long-Term Liabilities	-	-	0.38	0.38	0.7
Total Liabilities	144.5	122.96	417.81	441.87	453.75
Common Stock	1.77	1.71	1.69	1.55	1.53
Additional Paid-In Capital	2,765	2,145	2,019	1,608	1,504
Retained Earnings	-1,539	-1,116	-970.99	-645	-354.42
Comprehensive Income & Other	2.02	0.64	-6.89	-2.5	-0.25
Total Common Equity	1,230	1,031	1,042	962.29	1,151
Shareholders' Equity	1,230	1,031	1,042	962.29	1,151
Total Liabilities & Equity	1,374	1,154	1,460	1,404	1,604
Total Debt	54.32	52.24	60.35	64.01	68.87
Net Cash (Debt)	1,137	982.27	1,276	1,227	1,434
Net Cash Growth	15.79%	-23.01%	4.00%	-14.42%	274.57%
Net Cash Per Share	6.92	7.15	10.16	10.10	12.72
Filing Date Shares Outstanding	145.22	139.16	136.68	122.83	120.98
Total Common Shares Outstanding	144.22	138.39	135.97	122.28	120.53
Working Capital	762.23	986.16	1,008	518.99	1,424
Book Value Per Share	8.53	7.45	7.67	7.87	9.55
Tangible Book Value	1,230	1,031	1,042	962.29	1,151
Tangible Book Value Per Share	8.53	7.45	7.67	7.87	9.55
Machinery	60.37	50.35	37.6	32.97	26.91
Leasehold Improvements	46.91	41.24	43.7	35.24	34.74

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q